Publications
185
Citations
5,086
Est. group size
~21
Recurring co-author estimate
Active years
20
Publishing since 2007
Joal D. Beane's research focuses on surgical treatment of cancers of the pancreas, liver, bile duct, and gallbladder, as well as retroperitoneal sarcomas, with attention to how surgical decisions (like margin status or organ removal) affect patient outcomes. Some recent work also touches on cellular immunotherapy approaches, such as engineered tumor-infiltrating lymphocytes, for treating solid tumors and melanoma. The overall body of work combines clinical outcomes research in surgical oncology with emerging interest in immune-based cancer therapies.
Publication output has grown substantially over the last decade, with a notable surge in 2023-2024 following more moderate and variable activity in earlier years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- ASO Author Reflections: Multivisceral Versus Tumor-Only Resection in Retroperitoneal Liposarcoma
Annals of Surgical Oncology · 2024
- 747 Phase 1 trial of LYL845, an autologous tumor-infiltrating lymphocyte (TIL) therapy enhanced with epigenetic reprogramming, for the treatment of advanced solid tumors
Regular and Young Investigator Award Abstracts · 2023
- Supplemental figure 5 from Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
2023
- supplemental figure legend from Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
2023
- Supplemental figure 1 from Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
2023
- supplemental figure legend from Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
2023
- Supplemental figure 5 from Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
2023
- Supplemental figure 2 from Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
2023
- Supplemental figure 3 from Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
2023
- Supplemental figure 4 from Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
2023
- Data from Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
2023
- Data from Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
2023
- Supplemental figure 3 from Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
2023
- Supplemental figure 4 from Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
2023
- Supplemental figure 1 from Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
2023
- Annals of Surgical Oncology×26
- HPB×20
- Annals of Surgery×13
- Surgery×11
- Journal of Gastrointestinal Surgery×8
- Eugene P. Ceppa
Medicine · Indiana University
- Michael G. House
Medicine · Indiana University
- Atilla Nakeeb
Medicine · Indiana University
- Alexandra M. Roch
Medicine · Indiana University
- Nicholas J. Zyromski
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile